Clinical Trials Browser

Phase 1/2 × Pancreatic Neoplasms × Pancrelipase × Clear all

NCT05642962 2026-02-25

Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Phase 1/2 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT02985801 2021-03-15

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Phase 1/2 Terminated

16 enrolled 5 charts

Gastrointestinal

Exocrine Pancreatic Insufficiency, Pancreatic Neoplasms